View in EDS HTML Full Text PDF Full Text

12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.
Authors: Han B; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Liu W; Jingyuan County Center for Disease Control and Prevention, Baiyin 730600, China., Du J; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China., Liu H; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Zhao T; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Yang S; Jingyuan County Center for Disease Control and Prevention, Baiyin 730600, China., Wang S; Department of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China., Zhang S; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Liu B; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China., Liu Y; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China., Cui F; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.
Source: Vaccines [Vaccines (Basel)] 2021 Nov 29; Vol. 9 (12). Date of Electronic Publication: 2021 Nov 29.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34960153
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Han+B%22">Han B</searchLink>; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; Jingyuan County Center for Disease Control and Prevention, Baiyin 730600, China.<br /><searchLink fieldCode="AU" term="%22Du+J%22">Du J</searchLink>; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Zhao+T%22">Zhao T</searchLink>; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Yang+S%22">Yang S</searchLink>; Jingyuan County Center for Disease Control and Prevention, Baiyin 730600, China.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Department of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Liu+B%22">Liu B</searchLink>; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Cui+F%22">Cui F</searchLink>; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2021 Nov 29; Vol. 9 (12). <i>Date of Electronic Publication: </i>2021 Nov 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34960153
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/vaccines9121407
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Han B
      – PersonEntity:
          Name:
            NameFull: Liu W
      – PersonEntity:
          Name:
            NameFull: Du J
      – PersonEntity:
          Name:
            NameFull: Liu H
      – PersonEntity:
          Name:
            NameFull: Zhao T
      – PersonEntity:
          Name:
            NameFull: Yang S
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Zhang S
      – PersonEntity:
          Name:
            NameFull: Liu B
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Cui F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 11
              Text: 2021 Nov 29
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2076-393X
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Vaccines
              Type: main
ResultId 1